Skin surveillance of a U.K. paediatric transplant population

British Journal of Dermatology

Volumn 156, Issue 1, 2007, Pages 45-50

  Thomson, M A ^a   Suggett, N R ^b   Nightingale, P G ^c   Milford, D V ^a   Baumann, U ^a   Kelly, D A ^a   Moss, C ^a   Hill, V A ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Atypical naevi; Dysplastic naevi; Immunosuppression; Melanoma; Skin cancer; Solid organ transplantation

Indexed keywords

AZATHIOPRINE; CISPLATIN; CYCLOSPORIN; DOXORUBICIN; METHYLPREDNISOLONE; PREDNISOLONE; RAZOXANE; SUNSCREEN; TACROLIMUS;

ADOLESCENT; ARTICLE; DEMOGRAPHY; DYSPLASTIC NEVUS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; HEPATOBLASTOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERVIEW; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; NEVUS; PATIENT EDUCATION; PHENOTYPE; PRECANCER; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; SKIN CANCER; SKIN EXAMINATION; SUN EXPOSURE; SUNBURN; UNITED KINGDOM;

ADOLESCENT; ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSION; MALE; MELANOMA; NEVUS, PIGMENTED; RISK FACTORS; SKIN NEOPLASMS; SUNBURN; TRANSPLANTATION;

EID: 33845526187     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07546.x     Document Type: Article

References (27)

1. Ramsay HM, Fryer AA, Reece S et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000; 36:167-76.
2. UK Transplant. National Transplant Database and Organ Donor Register. Bristol, UK Transplant, 2005.
3. Bucuvalas JC, Ryckman FC. Long term outcome after liver transplantation in children. Paediatr Transplant 1998; 2:56-63.
4. Offner G, Latta K, Hoyer P et al. Kidney transplanted children come of age. Kidney Int 1999; 55:1509-17.
5. Nocera A, Ghio L, Dall'Amico R et al. De novo cancers in paediatric renal transplant recipients: a multicentre analysis within the North Italy Transplant programme, Italy. Eur J Cancer 2000; 36:80-6.
6. Wingen AM, Wiesel M, Möhring K et al. Malignancies in children with renal replacement. Transplant Proc 1994; 26:5-6.
7. Euvrard S, Kanitakis J, Cochat P, Claudy A. Skin cancers following pediatric organ transplantation. Dermatol Surg 2004; 30:616-21.
8. Coutinho HM, Groothoff JW, Offringa M et al. De novo malignancy after paediatric renal replacement therapy. Arch Dis Child 2001; 85:478-83.
9. Gruber SA, Gillingham K, Sothern RB et al. Cancer development in pediatric primary renal allograft recipients. Transplant Proc 1994; 26:3-4.
10. Penn I. De novo malignancy in pediatric organ transplant recipients. Pediatr Transplant 1998; 2:56-63.
11. Holly EA, Kelly JW, Shpall SN et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17:459-68.
12. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989; ii:487-90.
13. Grob JJ, Gouvernet J, Aymar D et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990; 66:387-95.
14. Barker JNW, Macdonald DM. Eruptive dysplastic naevi following renal transplantation. Clin Exp Dermatol 1988; 13:123-5.
15. McGregor JM, Barker JNW, Macdonald DM. The development of excess numbers of melanocytic naevi in an immunosuppressed identical twin. Clin Exp Dermatol 1991; 16:131-2.
16. Smith CH, McGregor JM, Barker JNW et al. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993; 28:51-5.
17. Euvrard S, Kanitakis J, Cochat P et al. Skin diseases in children with organ transplants. J Am Acad Dermatol 2001; 44:932-9.
18. Sorahan T, Ball PM, Grimley RP et al. Benign pigmented nevi in children from Kidderminster, England: prevalence and associated factors. J Am Acad Dermatol 1990; 22:747-50.
19. Pope DJ, Sorahan T, Marsden JR et al. Benign pigmented nevi in children. Prevalence and associated factors: The West Midlands, United Kingdom Mole Study. Arch Dermatol 1992; 128:1201-6.
20. Grob JJ, Andrac L, Romano MH et al. Dysplastic naevus in non-familial melanoma. A clinicopathological study of 101 cases. Br J Dermatol 1988; 118:745-52.
21. Roush GC, Nordhead JJ, Forget B et al. Independence of dysplastic nevi from total nevi in determining risk for non familial melanoma. Prev Med 1988; 17:273-9.
22. Slade J, Marghoob AA, Salopek TG et al. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol 1995; 32:479-94.
23. Kelly JW, Rivers JK, MacLennan R et al. Sunlight: a major risk factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994; 30:40-8.
24. Gallagher RP, McLean DI, Yang CP et al. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Arch Dermatol 1990; 126:770-6.
25. Gallagher RP, McLean DI. The epidemiology of acquired melanocytic naevi. A brief review. Dermatol Clin 1995; 13:595-603.
26. Autier P, Dore JF, Cattauzza MS et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children: European Organisation for Research and Treatment of Cancer melanoma cooperative group. J Natl Cancer Inst 1998; 90:1873-80.
27. Azizi E, Iscovich J, Pavlotsky F et al. Use of sunscreen is linked with elevated nevi counts in Israeli school children and adolescents. Melanoma Res 2000; 10:491-8.